Position in LQDA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,950,173
New position
Shares Held
78,171
first reported quarter
Ownership
0.088%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 49.79468089189085.ToString("F0")%
Shared 0.ToString("F0")%
None 50.20531910810915.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ESSEX INVESTMENT MANAGEMENT CO LLC holds $19,841,445 across 5 Drug Manufacturers - Specialty & Generic names. LQDA ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
249,278 | $12,002,735 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
|
747,769 | $4,337,060 | |
| 3 | LQDA |
Liquidia Corp
This page
|
78,171 | $2,950,173 | |
| 4 | ETON |
Eton Pharmaceuticals, Inc.
|
20,182 | $498,091 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
4,295 | $53,386 |
All Filings in LQDA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,950,173 | 78,171 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||